Avanos Medical and Siemens Healthineers Collaborate to Advance Integrated Solutions for Outpatient and Interventional Pain Management
Rhea-AI Summary
Avanos (NYSE: AVNS) and Siemens Healthineers announced a strategic co-marketing agreement to integrate Avanos radiofrequency ablation (RFA) technologies with Siemens mobile C-arm imaging systems for outpatient and interventional pain management.
The collaboration targets ambulatory surgery centers, hospitals, and interventional pain practices in the U.S., focusing on joint education, sales training, and marketing to promote a combined workflow that aims to improve procedural accuracy, efficiency, and consistency in patient care.
Positive
- None.
Negative
- None.
News Market Reaction – AVNS
In the Jan 20 session, AVNS gained 0.08%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jan 07 | Conference participation | Positive | +4.8% | JP Morgan Healthcare Conference presentation and webcast announcement. |
| Nov 05 | Quarterly earnings | Negative | -5.7% | Q3 2025 net loss and goodwill impairment despite modest sales growth. |
| Oct 27 | Earnings call notice | Neutral | -0.8% | Scheduling and access details for Q3 2025 earnings conference call. |
| Oct 23 | Business divestiture | Neutral | -0.3% | Agreement to sell US Game Ready orthopedic rental business to WRS Group. |
| Sep 15 | Strategic acquisition | Positive | +0.4% | Acquisition of Nexus Medical to bolster nutrition and medication delivery. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent AVNS news events have mostly seen modest price reactions that generally align with the positive or negative tone of the announcements.
Over the last several months, Avanos Medical reported Q3 2025 results with modest sales growth but a net loss and goodwill impairment, announced restructuring with executive role eliminations, and completed the Nexus Medical acquisition to strengthen Specialty Nutrition Systems. Asset divestiture of the US Game Ready orthopedic rental business and participation in the J.P. Morgan conference rounded out activity. Today’s collaboration with Siemens Healthineers extends this strategic shift toward focused pain management and integrated care solutions.
Key Terms
radiofrequency ablation medical
ambulatory surgery centers medical
mobile c-arm systems technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
As more pain management procedures shift to outpatient settings, providers are seeking versatile, cost-effective systems that streamline workflow and improve clinical outcomes. Together, Avanos and Siemens Healthineers will equip ambulatory surgery centers (ASCs), hospitals, and interventional pain practices with complementary technologies that enhance accuracy, efficiency, and consistency in patient care.
"At Avanos, we're continuously looking for smart, strategic ways to deliver greater value to our customers," said Dave Pacitti, Chief Executive Officer of Avanos Medical. "Collaborating with Siemens Healthineers combines our RFA expertise with leading imaging technology to help providers work smarter, improve procedural precision, and expand access to advanced pain management in the outpatient setting."
Siemens Healthineers mobile C-arm systems, including the Cios Select and Cios Flow, deliver advanced imaging, maneuverability, and reliability, enabling accuracy and consistency across procedures. Paired with Avanos' technologies, they create a seamless workflow that supports smoother operations and better patient outcomes.
"Our mobile c-arm systems are designed to improve clinical performance and simplify daily procedures," said Christiana Gallagher, Head of Mobile C-Arms,
The co-marketing agreement will initially focus on the U.S. market, with both companies collaborating on education, sales training, and joint marketing initiatives to increase awareness of the combined solution's clinical and operational benefits.
About Avanos Medical
Avanos Medical (NYSE: AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that help patients get back to what matters. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands globally and holds leading market positions in multiple product categories. For more information, visit www.avanos.com and follow Avanos Medical on X (@AvanosMedical), LinkedIn, and Facebook.
View original content to download multimedia:https://www.prnewswire.com/news-releases/avanos-medical-and-siemens-healthineers-collaborate-to-advance-integrated-solutions-for-outpatient-and-interventional-pain-management-302665127.html
SOURCE Avanos Medical